A key step towards reducing the burden of central nervous system (CNS) disorders is the identification of disease-specific biomarkers that can help predict, monitor, and guide treatment development.

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...

Guanosine, a purine nucleoside, has emerged as a potent modulator within the central nervous system (CNS), contributing to neuroprotection through a diverse array of mechanisms. It plays a critical ...

The central nervous system (CNS) critically depends on the integrity of oligodendrocytes, specialised glial cells responsible for the formation and maintenance of myelin sheaths. Myelin not only ...

Learning how cells in the brain regulate their response to injury and disease is informing the understanding of neurological disorders and uncovering new paths for treatment. Findings from a new study ...

Researchers at Lund University in Sweden have created a method that makes it possible to transform the brain's support cells into parvalbumin-positive cells. These cells act as the brain's ...

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...

WEST LAFAYETTE, Ind. – Purdue University researchers have created an electronic chip that may provide improved support for the hundreds of millions of people worldwide the World Health Organization ...

Neuroscience companies have raised more money from VCs in recent years, thanks to new research. In 2021, private biotech firms targeting neurological diseases raised $2.61 billion from investors. Here ...